Insulin-activated, K+-channel-sensitive Akt pathway is primary mediator of ML-1 cell proliferation

Taylor B Guo1, Jiawei Lu, Tie Li

  • 1Health Science Center, Shanghai Institute of Biological Sciences, Chinese Academy of Sciences, Shanghai Second Medical University, Shanghai, China.

Insights

Voltage-gated potassium channels regulate cell proliferation. Blocking these channels with 4-aminopyridine (4-AP) inhibited leukemia cell growth by interfering with insulin signaling pathways like MAPK/ERK and Akt.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Voltage-gated potassium channels influence cell proliferation.
  • Growth factors like insulin stimulate cell division through signaling pathways.

Purpose of the Study:

  • To investigate the role of voltage-gated potassium channels in regulating leukemia cell proliferation.
  • To determine the effect of 4-aminopyridine (4-AP) on insulin-stimulated ML-1 cell proliferation and associated signaling pathways.

Main Methods:

  • ML-1 cells were treated with 4-AP, barium, or tetraethylammonium to suppress potassium channel activity.
  • Insulin stimulation was used to induce proliferation and activate MAPK/ERK and Akt pathways.
  • Flow cytometry analyzed cell cycle progression.

Main Results:

  • 4-AP, barium, and tetraethylammonium inhibited EGF- and insulin-stimulated ML-1 cell proliferation.
  • 4-AP prevented insulin-induced phosphorylation of ERK1/2 and Akt.
  • 4-AP attenuated cell cycle progression in insulin-stimulated ML-1 cells.

Conclusions:

  • A 4-AP-sensitive potassium channel is crucial for ML-1 cell proliferation.
  • This channel impacts multiple signal transduction pathways activated by insulin.
  • Targeting these channels could offer therapeutic strategies for leukemia.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...